clinical trials

Verily lures major pharmas with promise of speedier clinical research
Verily lures major pharmas with promise of speedier clinical research
BioPharma Dive
Verily
Alphabet
clinical trials
Pfizer
Novartis
Sanofi
Otsuka
Flag link:
Ocular's sustained-release insert misses bull's-eye in phase 3 glaucoma trial
Ocular's sustained-release insert misses bull's-eye in phase 3 glaucoma trial
Fierce Biotech
Ocular Therapeutix
glaucoma
clinical trials
OTX-TP
Flag link:
BioCryst shares are blasted as a PhIII HAE 'success' underwhelms analysts
BioCryst shares are blasted as a PhIII HAE 'success' underwhelms analysts
Endpoints
Biocryst
HAE
clinical trials
BCX7353
Flag link:
Merck’s Keytruda fails in triple negative breast cancer trial
Merck’s Keytruda fails in triple negative breast cancer trial
Pharmaforum
Merck
Keytruda
clinical trials
triple negative breast cancer
Flag link:
Adverum Up as FDA Lifts Hold on Cohort of Wet AMD Study
Adverum Up as FDA Lifts Hold on Cohort of Wet AMD Study
Yahoo/Zacks.com
Adverum Biotechnologies
FDA
clinical trials
ADVM-022
wet age-related macular degeneration
Flag link:
FDA and Infant Bacterial Therapeutics agree on the design of Phase III study
FDA and Infant Bacterial Therapeutics agree on the design of Phase III study
CP Wire
Infant Bacterial Therapeutics
necrotizing enterocolitis
FDA
clinical trials
IBP-9414
Flag link:
Morphosys to take on CAR-Ts in NHL with promising antibody
Morphosys to take on CAR-Ts in NHL with promising antibody
Pharmaforum
MorphoSys
Celgene
Revlimid
non-Hodgkin lymphoma
clinical trials
tafasitamab
Flag link:
AstraZeneca's Fasenra offers severe asthma patients 2 years of benefits: analysis
AstraZeneca's Fasenra offers severe asthma patients 2 years of benefits: analysis
Fierce Pharma
AstraZeneca
Fasenra
severe asthma
asthma
clinical trials
Flag link:
T3D Therapeutics Receives $9 Million NIH Grant to Advance Alzheimer's Clinical Trial
T3D Therapeutics Receives $9 Million NIH Grant to Advance Alzheimer's Clinical Trial
BioSpace
T3D Therapeutics
NIH
Alzheimer's disease
clinical trials
T3D-959
Flag link:
Upcoming events – Phase III data for Chiasma and Novartis
Upcoming events – Phase III data for Chiasma and Novartis
EP Vantage
Chiasma
acromegaly
Mycapssa
clinical trials
multiple sclerosis
Novartis
ofatumumab
Flag link:
Actuate raises $22M to expand GSK-3β cancer trial
Actuate raises $22M to expand GSK-3β cancer trial
Fierce Biotech
Acutate Therapeutics
clinical trials
GSK-3β
cancer
Flag link:
Agios Pharma's Tibsovo Shows Positive Results in Phase III for Another Cancer Indication
Agios Pharma's Tibsovo Shows Positive Results in Phase III for Another Cancer Indication
BioSpace
Agios Pharmaceuticals
Tibsovo
ivosidenib
clinical trials
cholangiocarcinoma
Flag link:
Pfizer’s Abrocitinib yields positive results in phase 3 moderate to severe AD trial
Pfizer’s Abrocitinib yields positive results in phase 3 moderate to severe AD trial
Pharmaceutical Business Review
Pfizer
clinical trials
PF-04965842
atopic dermatitis
Flag link:
Allegro announces positive results of ex-US proof-of-concept trial with ALG-1007 for dry eye disease
Allegro announces positive results of ex-US proof-of-concept trial with ALG-1007 for dry eye disease
Pharmaceutical Business Review
Allegro
clinical trials
ALG-1007
dry eye disease
Flag link:
GenSight’s Eye Disease Gene Therapy Shows Sustained Vision Improvement
GenSight’s Eye Disease Gene Therapy Shows Sustained Vision Improvement
BioSpace
Gensight Biologics
clinical trials
gene therapy
LHON
Flag link:
FDA tells ImmunoGen to run a second phase 3, sinking stock
FDA tells ImmunoGen to run a second phase 3, sinking stock
Fierce Biotech
Immunogen
mirevtuximab soravtansine
ovarian cancer
clinical trials
Flag link:
Almost Half of All New Drug Approvals in 2018 Relied on One Clinical Trial
Almost Half of All New Drug Approvals in 2018 Relied on One Clinical Trial
RAPS.org
drug approvals
FDA
clinical trials
Flag link:
Myovant hits goal in uterine fibroid phase 3, teeing up AbbVie showdown
Myovant hits goal in uterine fibroid phase 3, teeing up AbbVie showdown
Fierce Biotech
Myovant Sciences
Relugolix
clinical trials
uterine fibroids
AbbVie
Elagolix
Flag link:
Grail, the liquid biopsy startup, picks an approach for its cancer test
Grail, the liquid biopsy startup, picks an approach for its cancer test
Stat
Grail
diagnostics
liquid biopsy
cancer
clinical trials
Flag link:
Biotech hits the brakes on their PhIII pivotal for a lead antibiotic as investigators track a high rate of kidney injuries
Biotech hits the brakes on their PhIII pivotal for a lead antibiotic as investigators track a high rate of kidney injuries
Endpoints
Polyphor
clinical trials
antibiotics
murepavadin
nosocomial pneumonia
Flag link:

Pages